In a significant move that promises to reshape the landscape of clinical research, Clinetic, a burgeoning healthtech company, has announced the successful closure of its Series A financing round. This round was spearheaded by Sopris Capital, a venture capital firm with a keen focus on technology-driven healthcare solutions.
Key Highlights
- Aiming High with the Funding: The newly acquired funds are set to propel Clinetic’s mission forward. The company plans to fast-track its patient recruitment initiatives, expand its real-world data capabilities, and foster deeper ties with its network of data-connected health systems. Additionally, this will pave the way for collaborations with an increasing roster of life science customers.
- Addressing a Crucial Challenge: Patient recruitment stands as one of the most daunting challenges in clinical trial execution. Many sites grapple with meeting enrollment targets, leading to expensive delays for research sponsors. Clinetic’s platform is designed to simplify and expedite patient recruitment by enabling health systems to securely leverage their electronic health record (EHR) data and patient relationships. This not only accelerates patient recruitment but also provides researchers with profound, timely clinical insights for real-world data studies.
- Leadership Insights: Tom Kaminski, the co-founder and CEO of Clinetic, expressed his excitement about the partnership with Sopris Capital. He emphasized the transformative potential of Clinetic’s data-driven software platform, which streamlines manual tasks for both health systems and life science companies. The ultimate goal? To complete studies more swiftly and introduce innovative therapies to enhance patient care.
- Sopris Capital’s Perspective: Mark Groner, a Partner at Sopris Capital, highlighted the unique and compelling value proposition of Clinetic. He underscored the platform’s potential to provide deep clinical data insights and streamline patient recruitment, addressing a pressing need in clinical research and healthcare.
About Clinetic:
Clinetic is a trailblazing health technology company that taps into the vast potential of electronic health record (EHR) data to accelerate clinical research and evidence generation. By enabling a growing network of health systems to efficiently identify and activate patients for clinical research through EHR-integrated workflows, Clinetic aims to expedite studies, offering greater visibility and ultimately paving the way for new therapeutic advancements to enhance patient care. For more details, visit Clinetic.
About Sopris Capital:
Sopris Capital is a venture capital firm that invests growth equity in technology-enabled business services and SaaS companies addressing critical pain points. With a vision to be a value-added partner to rapidly growing companies, Sopris Capital seeks to invest in businesses with a validated model, a proven product/market fit, and a management team poised to seize the opportunity ahead. Learn more at Sopris Capital.
Source: Business Wire
SoH's Take
Congrats to Clinetic on their Series A funding!
